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Recent data indicate that loss of the protective
telomeric capping function leads to active degrada-
tion of the telomeric G-strand overhang and DNA
ligase IV-mediated non-homologous end joining.
These molecular events may contribute to genomic
instability early in tumorigenesis.
Dating back to the pioneering studies of McClintock,
the essential function of telomeres to protect the ends
of linear chromosomes has been inferred cytogeneti-
cally by the end-to-end fusions and dicentric chromo-
somes that appear when telomere function is lost
(reviewed in [1]). In the recent years, interest in telom-
ere end protection has escalated because of mounting
evidence that loss of this function might contribute sig-
nificantly to the genome instability that drives early
tumorigenesis (reviewed in [2]). Indeed, the recurrent
non-reciprocal chromosomal translocations observed
in many human cancers may be, in part, a footprint of
a phase of tumor development prior to restabilization
of chromosome ends. New work by de Lange and
colleagues [3], published recently in Currrent Biology,
pushes forward our knowledge of the molecular events
that underlie the formation of chromosome end-to-end
fusions in cases of telomere dysfunction, and thus
deepens our understanding of events that may occur
in the early stages of tumorigenesis.
Telomeres consist of tandem repeats of simple G-
rich sequence, which terminate with a single-stranded
extension of the G-rich strand. It is not telomeric DNA
per se, but rather the association of an ensemble of
proteins with telomeric DNA, that is essential for the
formation of a protective cap structure. In human cells,
a central component of the end-capping structure is
the telomeric double-stranded DNA binding protein
TRF2 [4]. Titration of endogenous TRF2 away from
telomeres, for example by expression of a dominant-
negative form of TRF2, readily induces chromosome
end-to-end fusions [5]. In their new study, de Lange
and colleagues [3] have revealed significant molecular
details about the events that give rise to these initially
cytogenetically defined structures.
It has long been hypothesized that dysfunctional
telomeres are recognized as DNA double-strand
breaks (DSBs), and when recognized as such, are
subject to DSB repair activities. Until recently,
however, the pathway mediating the aberrant repair of
dysfunctional telomeres was not defined. Previous
studies showed that, in cells with diminished TRF2
function, the appearance of new telomeric restriction
fragments of a size consistent with fused telomeres
coincides with the presence of telomere associations
cytogenetically. But whether these novel telomeric
fragments are generated by ligation of telomeric
strands or by non-covalent nucleic acid interactions,
perhaps involving the telomeric G-strand overhangs,
has remained an open question. 
Resolving this issue, Smogorzewska et al. [3] found
that the novel telomeric fragments were still seen
under denaturing conditions, arguing strongly against
their being caused by non-covalent nucleic acid
interactions. Furthermore, unlike terminal telomeric
restriction fragments, the new telomeric fragments
were not sensitive to the exonuclease Bal31, indicat-
ing that the telomeric repeats are not at the physical
end of these fragments. This implies that the chromo-
some end fusions observed cytogenetically when
telomere end protection fails are created by the actual
ligation of the G-rich strand of one telomere to the C-
rich strand of another telomere.
The inference that chromosome end-to-end fusions
reflect telomere–telomere ligation raises the obvious
question of which repair pathway is acting on these
dysfunctional telomeres? Because of the uniform
directionality of telomeric sequences — the G-rich
strand always proceeds 5′-to-3′ — homologous
recombination would fail to give rise to covalently
fused telomeres. In contrast, non-homologous end
joining (NHEJ) would be predicted to give rise readily
to the observed structures. The new observation [3]
that mouse cells lacking DNA ligase IV — the ligase
that mediates NHEJ — fail to accumulate telomere
fusions in response to diminished TRF2 function indi-
cates that NHEJ is indeed the culprit.
Similarly, the Ku heterodimer, another component of
the NHEJ pathway, was recently shown to be required
for the fusion of critically short telomeres that arise in
telomerase-deficient mouse cells [6]. The Ku story is a
bit more complex, however, because this essential
player in the NHEJ pathway is also a component of
telomeric chromatin, and is itself required for normal
chromosome end protection [7–9]. But unlike Ku, DNA
ligase IV does not play a role in normal telomere metab-
olism. Hence the results presented by Smogorzewska
et al. [3] expand the role of the NHEJ pathway by
demonstrating its activity at ends that retain their com-
plement of telomeric DNA. Thus, loss of a protein com-
ponent of the protective cap may be sufficient for the
chromosome ends to be recognized as DSBs and
acted upon by the NHEJ machinery. It is this key event
that generates the dicentric chromosomes, which sec-
ondarily contribute to genomic instability.
Still, the conundrum remains: how are certain com-
ponents of the NHEJ pathway, such as Ku, required for
both chromosome end protection and fusion of chro-
mosome ends when capping function is lost? Presum-
ably, the activities of these components are influenced
by other telomere-associated factors, as has been
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observed for Ku in fission yeast [10]. Furthermore,
fusions in Ku-deficient mouse cells appear to occur
independently of G-strand overhangs [9], suggesting a
fundamental difference from the con-sequences of
TRF2 deficiency (see below). Thus, it will be important
to establish whether the telomere end-to-end associa-
tions observed cytogenetically in Ku-deficient cells are
similarly caused by covalent ligation of chromosomes
rather than non-covalent nucleic acid interactions, for
example involving the G-strand overhang.
Because of the dynamics of the DNA structure at
chromosome termini during the cell cycle, determining
whether leading and/or lagging strand telomeres are
subject to end-to-end fusions, and in which phase(s)
of the cell cycle fusions occur, has specific impli-
cations for models of the mechanism of chromosome
end protection. Chromosome replication by the con-
ventional DNA replication machinery gives rise to a
blunt end on the leading strand telomere, whereas,
removal of the RNA primer of the ultimate Okazaki
fragment is predicted to leave a short G-strand over-
hang on the lagging strand telomere. Yet, long G-
strand overhangs are detected at human chromosome
termini regardless of whether they are products of
leading or lagging strand synthesis, or whether the
cells are actively dividing or quiescent, implicating a
processing activity in generating functional telomere
ends [11,12].
Using a technique called chromosome orientation
fluorescence in situ hybridization, Bailey et al. [13]
examined the specific ends engaged in fusion events.
This technique allowed them to differentiate termini
generated by leading versus lagging strand DNA repli-
cation machinery. Using the same dominant-negative
form of TRF2 as the de Lange group, they found that
fusion events were restricted to telomeres replicated
by leading strand synthesis; fusions leading to lagging
strand termini, as would occur between sister chro-
matids, or fusions between two lagging strand termini
were not observed. Furthermore, because of the
absence of chromosome type fusions, the fusion
events appeared restricted to the post-replicative
phase of the cell cycle (Figure 1). These results
suggested a model in which TRF2 provides end
protection specifically to leading strand telomeres
following DNA synthesis, perhaps secondary to a role
in post-replicative processing of the leading strand
telomere blunt ends.
Smogorzewska et al. [3], however, obtained a dif-
ferent set of results. They found that sister chromatid
type fusions were readily detected in cells expressing
the dominant-negative form of TRF2, indicating that
TRF2 prevents fusion of telomeres regardless of
whether they are the product of leading or lagging
strand synthesis (Figure 1). This is an important obser-
vation, because sister chromatid fusions might initiate
steps toward gene amplification, which is observed in
human tumors (reviewed in [1]). Even more striking
was the presence of chromosome type fusions in the
metaphase spreads, raising the possibility that TRF2
is also required to protect chromosome ends prior to
DNA replication (Figure 1).
To address this question, Smogorzewska et al. [3]
went on to show that chromosome type fusions could
still be detected when the period of telomere dys-
function and observation was restricted to a single cell
cycle, eliminating the possibility that chromosome
type fusions are replicated descendents of chromatid
type fusions from the previous cell cycle. Additionally,
the fused telomeric restriction fragments observed in
cells with diminished TRF2 function were still seen
even if the cells were prevented from progressing
through S phase, indicating their formation prior to
DNA synthesis. And thus, a model emerges with TRF2
as an equal opportunity protector, required at both
leading and lagging strand termini and both before
and after DNA synthesis.
What accounts for the striking differences between
the two studies [3,13]? Perhaps they reflect differences
in the DNA damage checkpoint status, function of the
NHEJ machinery, or even telomere structure, in the
primary human fibroblasts used by Smogorzewska et al.
[3] versus the human fibrosarcoma cell line used by
Bailey et al. [13]. Uncovering the differences between
the two model systems should present an excellent
opportunity to further dissect the molecular require-
ments for fusions at deprotected chromosome ends.
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Figure 1. Chromosomal products of NHEJ of dysfunctional
telomeres.
At the top is illustrated the consequences of NHEJ of dysfunc-
tional telomeres following DNA synthesis; sister and non-sister
chromatid type fusions are observed on metaphase spreads. At
the bottom is shown the generation of chromosome type
fusions as a consequence of fusion of dysfunctional telomeres
prior to DNA replication.
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As mentioned earlier, telomeres are normally pro-
cessed to generate long G-strand overhangs. This
structural feature has been at the core of many
models of telomere end protection. At the most sim-
plistic level, the very presence of a G-strand overhang
might serve as a protective mechanism against end-
to-end ligation by DNA ligase IV, and loss of telomere
end protection might reflect loss of the G-strand
overhang. In fact, it is striking that the profound end
protection defect in cells with diminished TRF2
function is not associated with a detectable loss of
duplex telomeric DNA [5].
Considering the possibility that TRF2 may be
involved in preventing loss of the protective G-strand
overhang, Smogorzewska et al. [3] observed a reduc-
tion in G-strand overhang abundance in G0 arrested
cells following TRF2 inhibition. Given this reduction
could not be attributed to passive loss during DNA
replication or to TRF2 being involved in post-replicative
telomere processing, this result pushes forth the model
that a key function of TRF2 is to protect the terminal G-
strand overhangs from active nucleolytic processing.
How exactly does TRF2, a telomeric double-stranded
DNA binding protein, mediate protection of the single-
stranded terminus? One possibility relates to the t-loop,
a lariat-like structure present at both ends of mam-
malian chromosomes, which appears to be generated
by cis-invasion of the terminal G-rich overhang into the
telomeric duplex tract [14]. In vitro studies have impli-
cated TRF2 in t-loop formation [14,15], and so one
model proposes that, in the absence of TRF2, the ter-
minal overhang is no longer sequestered by the t-loop,
and becomes susceptible to recognition and process-
ing as DNA damage [14,16]. Alternatively, TRF2 might
recruit the telomeric single-stranded DNA binding
protein, POT1 [17], to the chromosome terminus, which
then mediates end protection. Studies of interactions
between TRF2 and POT1, and of the contribution of
POT1 to chromosome end protection in human cells
should therefore be of great interest.
Focus on the molecular events described above has
been driven by the prediction that the chromosome
end fusions generated as a consequence of telomere
dysfunction could secondarily give rise to chromoso-
mal instability. For example, non-reciprocal transloca-
tions and deletions could arise as a consequence of
the recombinogenic DSBs created by rupture of
dicentric chromosomes during mitosis (reviewed in
[1]). This prediction was born-out by the detection of
an array of non-reciprocal translocations and terminal
deletions in human cells shortly after inhibition of
TRF2 function [3]. Similar results were observed in
mouse cells when examining the consequences of
telomere shortening due to a telomerase deficiency
[18]. Thus both models of telomere dysfunction, either
through loss of TRF2 function or telomere attrition,
lend strong support to the hypothesis that telomere
dysfunction may contribute to the chromosomal insta-
bility observed early in human cancer progression.
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